Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs iShares Silver Trust (SLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs iShares Silver Trust — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while iShares Silver Trust trades at $51.16 (market cap $28.90B). The key difference: GE HealthCare Technologies Inc. Common Stock and iShares Silver Trust are close in size by market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while iShares Silver Trust pays none. Which is the better fit depends on your goals.
| GEHC | SLV | |
|---|---|---|
Market Cap | $30.93B | $28.90B |
Volume | 5,033,451 | 36,248,796 |
Sector | Health | — |
52-Week High | $88.16 | $105.57 |
52-Week Low | $59.48 | $42.40 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 90 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SLV (iShares Silver Trust) trades at $53.49, down 1.58% amid bearish technical signals with 17 sell indicators versus 1 buy. The ETF shows minimal operational activity with $0 revenue but generated $2.17M net income in 2024, supported by $13.41B in total assets against negligible liabilities. Recent news highlights silver's volatility tied to Fed policy and Treasury yields, with prices pressured by hawkish rate expectations.
Outlook remains cautious as technical weakness and macroeconomic headwinds dominate. Silver's dual role as monetary and industrial metal exposes SLV to Fed policy shifts and dollar strength, though long-term demand catalysts like central bank buying offer potential upside. Risks include sustained rate hikes and industrial demand fluctuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About iShares Silver Trust
The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →
